Pomalidomide 4mg Capsules

Pomalidomide 4mg is an immunomodulatory medicine used with dexamethasone and sometimes other agents for previously treated multiple myeloma. It is selected according to earlier therapy and the pattern of relapse.
Swallow the capsules whole at a consistent time, with or without food, on the treatment days of the cycle. A common pattern is 21 days of treatment in a 28-day cycle. Do not open or chew the capsules.
Pomalidomide binds cereblon and changes targeted protein breakdown and immune signalling, reducing survival of susceptible myeloma cells.
Low blood counts, fatigue, constipation, diarrhoea and rash can occur. Blood clots, serious infection and severe skin reactions are important risks.
Severe fetal harm can occur. Pregnancy prevention and testing are essential. Blood counts and clot-prevention needs are assessed throughout treatment.
Can improve control of myeloma that has returned after earlier treatments.
Pomalidomide-containing combinations can increase venous and arterial clot risk, so prevention is selected for the individual regimen.
No. The severe risk to an unborn baby applies at all strengths.
A lower dose or treatment break can allow recovery from low counts or other toxicity while preserving ongoing treatment.
No. Donation is avoided during treatment and for the required period afterwards to prevent exposing a pregnant recipient.
Immunomodulatory agent: a medicine altering immune and tumour-cell activity. Cereblon: a protein involved in regulated protein breakdown. Relapsed myeloma: myeloma returning after a response.; AR: Pomalidomide 4mg كبسولات; FR: Pomalidomide 4mg gélules; PT: Pomalidomide 4mg cápsulas; ES: Pomalidomide 4mg cápsulas; RU: Pomalidomide 4mg капсулы; ID: Pomalidomide 4mg kapsul; VI: Pomalidomide 4mg viên nang; MS: Pomalidomide 4mg kapsul; TL: Pomalidomide 4mg mga kapsula; ZH-SG: Pomalidomide 4mg 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Pomalidomide 4mg Capsules under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pomalidomide 4mg Capsules